Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome
Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder caused by deficiency of the iduronate-2-sulfatase (IDS) enzyme, resulting in cellular accumulation of glycosaminoglycans (GAGs) throughout the body. Treatment of MPS II remains a considerable challenge as current enzyme replaceme...
Main Authors: | Annie Arguello, René Meisner, Elliot R. Thomsen, Hoang N. Nguyen, Ritesh Ravi, Jeffrey Simms, Iris Lo, Jessica Speckart, Julia Holtzman, Thomas M. Gill, Darren Chan, Yuhsiang Cheng, Chi-Lu Chiu, Jason C. Dugas, Meng Fang, Isabel A. Lopez, Hilda Solanoy, Buyankhishig Tsogtbaatar, Yuda Zhu, Akhil Bhalla, Kirk R. Henne, Anastasia G. Henry, Anthony Delucchi, Simona Costanzo, Jeffrey M. Harris, Dolores Diaz, Kimberly Scearce-Levie, Pascal E. Sanchez |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2021-10-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.145445 |
Similar Items
-
Insights into Hunter syndrome from the structure of iduronate-2-sulfatase
by: Mykhaylo Demydchuk, et al.
Published: (2017-06-01) -
In vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats
by: Will J. Costain, et al.
Published: (2025-01-01) -
Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain
by: Carolina Cardona, et al.
Published: (2019-05-01) -
Iduronate-2-sulfatase interactome: validation by yeast two-hybrid assay
by: Eliana Benincore-Flórez, et al.
Published: (2022-03-01) -
Production of active human iduronate-2-sulfatase (IDS) enzyme in Nicotiana benthamiana
by: Md Hasif Sinha, et al.
Published: (2024-10-01)